← Eichor
Study identifier: NCT05927818 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer

Condition: Sentinel Lymph Node · Ovarian Carcinoma  ·  Sponsor: Istanbul University

PhaseNA
Planned participants100
Who can joinFemale, 18 Years to 90 Years
Healthy volunteersNo

About this study

The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Mustafa ALBAYRAK, MD  ·  +90 532 687 10 51  ·  mustafaalbayrak@icloud.com

Yagmur MİNARECİ, MD  ·  +90 505 357 43 61  ·  yagmurminareci@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Istanbul UniversityIstanbul, Turkey, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05927818